Janssen-Cilag Aktiebolag
556024-0037ActiveDeveloping and delivering transformational pharmaceutical treatments for complex diseases globally.
Pharmaceutical Subsidiaryjnj.com
Yleiskatsaus
- 100–199
- Työntekijät
- 1–5mrd SEK
- Liikevaihto
- 1925
- Perustettu
Avainpäättäjät
Joaquin Duato
Chairman and Chief Executive Officer
John C. Reed, M.D., Ph.D.
Executive Vice President, Innovative Medicine, R&D
Eugene A. Woods
Board Member
James Swanson
Executive Vice President, Chief Information Officer
+19 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Janssen-Cilag Aktiebolag operates as a key subsidiary within Johnson & Johnson's Innovative Medicine sector. This division is dedicated to leading where medicine is going, focusing on rigorous science and compassion to address complex diseases. The organization develops and delivers transformational...
JANSSEN-CILAG AS